Skip to content
Labquality EQAS

Respiratory infections multiplex, nucleic acid detection

CLINICAL MICROBIOLOGY

Scheme information

Scheme
Respiratory infections multiplex, nucleic acid detection
Service by
Labquality
Target
Laboratories
Group
Clinical microbiology
Sub-group
Multiplex methods

Products

5300 / Respiratory infections multiplex, nucleic acid detection
Samples: 4 simulated samples, 1 mL each
Examinations: Direct multiplex nucleic acid detection. Pathogens included are adenovirus, bocavirus, B. parapertussis, B. pertussis, C. pneumoniae, coronavirus (OC43, 229E, NL63, HKU1), enterovirus, influenzavirus A/B, L. pneumophila, metapneumovirus, M. pneumoniae, parainfluenzavirus 1-4, rhinovirus, RSV A/B, SARS-CoV-2 and S. pneumoniae.
Rounds: FEB, MAY, SEP, NOV
Accrediation: SFS-EN ISO/IEC 17043:2023, FINAS, PT02. The qualitative analysis phase is accredited.
Results/sample set: 1
Additional information: During the period of one calendar year, a comprehensive selection of listed pathogens will be covered. Participation in all rounds throughout the year is strongly recommended to achieve the best possible coverage. The samples include hDNA.

Contact us

Leave us a contact request